Clinical Characteristics of Telogen Effluvium Induced by COVID-19 Infection: Integrative Review

January 2023 in “ Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida ”

Raquel de Souza Mota, Alexandre Braga Gomes, Arthur Henrique Silva da Fonseca, Nadine Vitore Barros Chaves Costa, Ana Viviane Herculano Santiago Silva, Lucas Pinto de Oliveira, Laura da Silva Nascimento, S. Santana, Andréa Cristina Vale de Souza Pereira, Tereza Cristina dos Reis Ferreira

TLDR COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.

The study reviewed 13 articles to investigate the clinical characteristics of Telogen Effluvium induced by COVID-19 infection. It found that women were predominantly diagnosed with this condition, which was characterized by intense hair loss, reduced hair density, and empty follicular units or units with only one hair. Some cases also showed decreased hair thickness and difficulty in bending the hair. The average time for the development of Telogen Effluvium was 2 months, with resolution occurring between 1 to 4 months.

View this study on revista.cpaqv.org →

Discuss this study in the Community →

Research cited in this study

20 / 20 results

research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19

July 2023 in “Regenerative Therapy”

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

research Post-Covid Telogen Effluvium

1 citations , December 2022 in “PubMed”

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

research Telogen Effluvium and COVID-19: A Case and a Brief Review of Literature

November 2022 in “Medicina”

COVID-19 may cause temporary hair loss due to the body's immune response.

research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review

12 citations , July 2022 in “Journal of Cosmetic Dermatology”

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication

8 citations , February 2022 in “Journal of Clinical Medicine”

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis

25 citations , February 2022 in “JAAD International”

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

research Pathological Sequelae of Long-Haul COVID

353 citations , February 2022 in “Nature Immunology”

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

research Red Nail Bands in Conjunction with Telogen Effluvium as a Post-COVID-19 Phenomenon

December 2021 in “Australasian Journal of Dermatology”

Red stripes on nails and hair loss may occur after COVID-19.

research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation

25 citations , December 2021 in “Journal of Medical Virology”

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

research Early-Onset Effluvium Secondary to COVID-19: Clinical and Histologic Characterization

7 citations , December 2021 in “Journal of The American Academy of Dermatology”

COVID-19 can cause hair loss starting as early as 18 days after infection.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations , August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium

32 citations , July 2021 in “Journal of The American Academy of Dermatology”

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients

18 citations , April 2021 in “Experimental Dermatology”

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2

3 citations , April 2021 in “Revista da Sociedade Portuguesa de Dermatologia e Venereologia”

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations , January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

28 citations , January 2021 in “Skin appendage disorders”

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study

51 citations , November 2020 in “Journal of the European Academy of Dermatology and Venereology”

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection

24 citations , August 2020 in “AJGP”

A woman's sudden hair loss was linked to her previous COVID-19 infection.

research Telogen Effluvium: A Review of the Literature

40 citations , May 2020 in “Cureus”

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.